Scientists reprogram Patients' own cells to hunt down cancer
Disease control
Ongoing
This early-phase study is testing a new personalized treatment called CAR T-cell therapy for non-Hodgkin lymphoma that has returned or hasn't responded to standard treatments. Doctors collect a patient's own immune cells, modify them in a lab to better recognize and attack cancer…
Phase: PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC